Gene · 2280
Papers1,820
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,820
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Proteomics Profiling of Bladder Cancer Tissues from Early to Advanced Stages Reveals NNMT and GALK1 as Biomarkers for Early Detection and Prognosis of BCa. | Int J Mol Sci | 2023 | 37834386 | PubTator, text mining | PubMed |
| Nicotine Exposure in a Phencyclidine-Induced Mice Model of Schizophrenia: Sex-Selective Medial Prefrontal Cortex Protein Markers of the Combined Insults in Adolescent Mice. | Int J Mol Sci | 2023 | 37834084 | PubTator, text mining | PubMed |
| First-in-human clinical trial of personalized neoantigen vaccines as early intervention in untreated patients with lymphoplasmacytic lymphoma. | Res Sq | 2023 | 37790486 | PubTator, text mining | PubMed |
| Mechanistic target of rapamycin (mTOR): a potential new therapeutic target for rheumatoid arthritis. | Arthritis Res Ther | 2023 | 37784141 | PubTator, text mining | PubMed |
| Multifaceted role of mTOR (mammalian target of rapamycin) signaling pathway in human health and disease. | Signal Transduct Target Ther | 2023 | 37779156 | PubTator, text mining | PubMed |
| ONC201/TIC10 enhances durability of mTOR inhibitor everolimus in metastatic ER+ breast cancer. | Elife | 2023 | 37772709 | PubTator, text mining | PubMed |
| Deconstructing Protein Binding of Sulfonamides and Sulfonamide Analogues. | JACS Au | 2023 | 37772190 | PubTator, text mining | PubMed |
| Silibinin Downregulates Types I and III Collagen Expression via Suppression of the mTOR Signaling Pathway. | Int J Mol Sci | 2023 | 37762688 | PubTator, text mining | PubMed |
| Multi-Omics Analysis Reveals the Pathogenesis of Growth-Disordered Raccoon Dog. | Int J Mol Sci | 2023 | 37762538 | PubTator, text mining | PubMed |
| The Long Scientific Journey of Sirolimus (Rapamycin): From the Soil of Easter Island (Rapa Nui) to Applied Research and Clinical Trials on β-Thalassemia and Other Hemoglobinopathies. | Biology (Basel) | 2023 | 37759601 | PubTator, text mining | PubMed |
| Lost in translation: a neglected mTOR target for lymphangioleiomyomatosis. | Eur Respir Rev | 2023 | 37758276 | PubTator, text mining | PubMed |
| Structural insights into the activation of ataxia-telangiectasia mutated by oxidative stress. | Sci Adv | 2023 | 37756394 | PubTator, text mining | PubMed |
| Raptor mediates the selective inhibitory effect of cardamonin on RRAGC-mutant B cell lymphoma. | BMC Complement Med Ther | 2023 | 37749558 | PubTator, text mining | PubMed |
| Formulation of cost-effective medium and optimization studies for enhanced production of rapamycin. | Microb Cell Fact | 2023 | 37730584 | PubTator, text mining | PubMed |
| mTOR signaling in hair follicle and hair diseases: recent progress. | Front Med (Lausanne) | 2023 | 37727765 | PubTator, text mining | PubMed |
| The prognostic and immunological role of FKBP1A in an integrated muti-omics cancers analysis, especially lung cancer. | J Cancer Res Clin Oncol | 2023 | 37715833 | PubTator, text mining | PubMed |
| Distinct disease features of acute and persistent genotype 3 hepatitis E virus infection in immunocompetent and immunosuppressed Mongolian gerbils. | PLoS Pathog | 2023 | 37703304 | PubTator, text mining | PubMed |
| Diagnostic and prognostic value of autophagy-related key genes in sepsis and potential correlation with immune cell signatures. | Front Cell Dev Biol | 2023 | 37701780 | PubTator, text mining | PubMed |
| Inhibition of Urban Particulate Matter-Induced Airway Inflammation by RIPK3 through the Regulation of Tight Junction Protein Production. | Int J Mol Sci | 2023 | 37686124 | PubTator, text mining | PubMed |
| Human iPSCs as Model Systems for BMP-Related Rare Diseases. | Cells | 2023 | 37681932 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2280/papers?page=6